Literature DB >> 10714619

Augmentation strategies in depression 2000.

J C Nelson1.   

Abstract

Augmentation strategies and combination treatments have become a popular method of treating refractory depression, enhancing therapeutic response in partial responders and increasing the likelihood of more rapid response. The evidence supporting these strategies will be reviewed, their methods of administration discussed, and the relative advantages and disadvantages considered.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10714619

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  8 in total

Review 1.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

2.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

Review 3.  What to do if an initial antidepressant fails?

Authors:  Roger S McIntyre; Aleksandra Müller; Deborah A Mancini; Eric S Silver
Journal:  Can Fam Physician       Date:  2003-04       Impact factor: 3.275

4.  The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Authors:  Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

5.  Sensorimotor modulation of mood and depression: in search of an optimal mode of stimulation.

Authors:  Resit Canbeyli
Journal:  Front Hum Neurosci       Date:  2013-07-30       Impact factor: 3.169

6.  The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial.

Authors:  Yves Chaput; Annick Magnan; Alain Gendron
Journal:  BMC Psychiatry       Date:  2008-08-28       Impact factor: 3.630

7.  Food and nutrient intake in relation to mental wellbeing.

Authors:  Reeta Hakkarainen; Timo Partonen; Jari Haukka; Jarmo Virtamo; Demetrius Albanes; Jouko Lönnqvist
Journal:  Nutr J       Date:  2004-09-13       Impact factor: 3.271

8.  Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder.

Authors:  Michael E Thase; Dalei Chen; John Edwards; Adam Ruth
Journal:  Int Clin Psychopharmacol       Date:  2014-11       Impact factor: 1.659
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.